Literature DB >> 29781506

Articular cartilage protection in Ctsk-/- mice is associated with cellular and molecular changes in subchondral bone and cartilage matrix.

Fabiana N Soki1, Ryu Yoshida2, David N Paglia2, Le T Duong3, Marc F Hansen1, Hicham Drissi4.   

Abstract

Osteoarthritis (OA) is a degenerative disease and a major cause of chronic disability in aging individuals. Cathepsin K (CatK), encoded by the Ctsk gene, has been implicated in the pathogenesis of pycnodysostosis and osteoporosis. The use of a selective inhibitor of CatK was recently shown to delay OA progression in rabbits. However, the cellular mechanisms underlying these protective effects remain unexplored. We examined articular cartilage maintenance and joint bone remodeling using Ctsk null mice (Ctsk-/- ) which underwent destabilization of the medial meniscus (DMM). We found that Ctsk-/- mice displayed delayed remodeling of subchondral and calcified cartilage by osteoclasts and chodroclasts respectively in DMM-induced osteoarthritis. While WT mice displayed a more severe OA phenotype than Ctsk-/- mice at 16 weeks, higher subchondral bone volume and lower trabecular spacing were also observed in surgically-induced OA joints of Ctsk-/- mice. However, no differences were seen in non-surgical controls. During OA progression, TRAP+ osteoclast numbers were increased in both WT and Ctsk-/- mice. However, Ctsk-/- mice had fewer physis-derived chondroclasts than WT when OA was present. These data suggest that CatK may differentially regulate chondroclastogenesis in the growth plate. Targeted PCR arrays of RNA harvested from laser captured osteoclasts in the subchondral bone and chondroclasts in the growth plate demonstrated differential expression of Atp6v0d2, Tnfrsf11a, Ca2, Calcr, Ccr1, Gpr68, Itgb3, Nfatc1, and Syk genes between WT and Ctsk-/- mice at 8- and 16-weeks post-DMM. Our data provide insight into the cellular mechanisms by which cathepsin K deletion delays OA progression in mice.
© 2018 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29781506     DOI: 10.1002/jcp.26745

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  6 in total

1.  Probiotic Composition and Chondroitin Sulfate Regulate TLR-2/4-Mediated NF-κB Inflammatory Pathway and Cartilage Metabolism in Experimental Osteoarthritis.

Authors:  Oleksandr Korotkyi; Alevtina Huet; Kateryna Dvorshchenko; Nazarii Kobyliak; Tetyana Falalyeyeva; Liudmyla Ostapchenko
Journal:  Probiotics Antimicrob Proteins       Date:  2021-01-18       Impact factor: 4.609

Review 2.  The Importance of the Knee Joint Meniscal Fibrocartilages as Stabilizing Weight Bearing Structures Providing Global Protection to Human Knee-Joint Tissues.

Authors:  James Melrose
Journal:  Cells       Date:  2019-04-06       Impact factor: 6.600

3.  Hyaluronan suppresses enhanced cathepsin K expression via activation of NF-κB with mechanical stress loading in a human chondrocytic HCS-2/8 cells.

Authors:  Mochihito Suzuki; Nobunori Takahashi; Yasumori Sobue; Yoshifumi Ohashi; Kenji Kishimoto; Kyosuke Hattori; Naoki Ishiguro; Toshihisa Kojima
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

Review 4.  Subchondral Bone Remodeling: A Therapeutic Target for Osteoarthritis.

Authors:  Xiaobo Zhu; Yau Tsz Chan; Patrick S H Yung; Rocky S Tuan; Yangzi Jiang
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 5.  Cathepsin K+ Non-Osteoclast Cells in the Skeletal System: Function, Models, Identity, and Therapeutic Implications.

Authors:  Nanyu Zou; Ran Liu; Changjun Li
Journal:  Front Cell Dev Biol       Date:  2022-07-13

6.  Whole-exome sequencing identified a novel variant in an Iranian patient affected by pycnodysostosis.

Authors:  Ehsan Razmara; Homeyra Azimi; Amirreza Bitaraf; Mohammad Ali Daneshmand; Mohammad Galehdari; Maryam Dokhanchi; Elika Esmaeilzadeh-Gharehdaghi; Masoud Garshasbi
Journal:  Mol Genet Genomic Med       Date:  2020-01-15       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.